Pillar

A technical research-workflow overview of peptide bond structure, geometry, hydrolytic stability, and laboratory handling for preclinical peptide researchers. ~155 chars.

Melanotan II (MT2): a technical research overview of this cyclic α-MSH analogue, covering receptor pharmacology, preclinical applications, and laboratory handling for researchers.

Epithalon (AEDG) tetrapeptide: preclinical research overview covering sequence origin, telomerase findings, antioxidant activity, epigenetic mechanisms, and lab handling.

A laboratory-focused research overview of tesamorelin: molecular structure, GHRH receptor mechanism, hepatic transcriptomic findings, and handling guidance for research use.

Research overview of MOTS-c, the 16-amino-acid mitochondrial-derived peptide: genomic origin, AMPK pathway mechanisms, and preclinical research applications.

A preclinical research overview of GHK-Cu: sequence, copper-chelation chemistry, ECM remodelling mechanisms, antioxidant signalling, and laboratory handling in research models.

KPV is the C-terminal tripeptide of α-MSH studied in preclinical models for immunomodulatory properties. Research overview of its mechanisms, applications, and lab handling.

This glossary defines the technical terminology common to research peptide sourcing, characterization, and laboratory application. Terms cover analytical methods, peptide chemistry, dosing calculations, and the compound classes most commonly studied in research settings.

Research peptides are synthetic short chains of amino acids — typically between 2 and 50 residues — supplied to laboratories and independent investigators for in vitro experimentation and preclinical study. The category spans a wide regulatory range. At one end are compounds with completed Phase 3 human clinical trial programs and current FDA and EMA approval…